Ares Capital

ARCCNASDAQUSD

THESIS ALERT

Email me when the ARCC thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$19.46
+$0.02 (+0.10%)Today 1M +4.74%
After hours$19.33−0.67%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$19.44
Prior regular-session close from the quote source.
$19.35–$19.50
Regular-session low and high so far today.
3.7M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 3 projected
Projected for 2027-02-03 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$17.40–$21.14
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own ARCC if Ares can keep sourcing private-credit assets at attractive spreads while avoiding the credit losses and funding stress that destroy BDC book value.

ARCC price history

Latest price$19.46Today+$0.02 (+0.10%)
ARCC +4.20%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Ares Capital’s specialty-finance platform continues to replenish the portfolio because borrowers still choose private credit over bank or syndicated-market alternatives.StrengtheningMateriality: High

    GAAP total assets at fiscal year-end increased from $20.843 billion in FY2021 to $31.235 billion in FY2025. If sourcing remains advantaged, ARCC can keep redeploying capital into income-producing assets; if deal flow migrates elsewhere, the portfolio and earnings base erode.

    Watch: Banks and the broadly syndicated loan market reopen aggressively and undercut private-credit pricing for ARCC’s target borrowers.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP total assets at fiscal year-end increased from $20.843 billion in FY2021 to $31.235 billion in FY2025.

    Open source ↗
  • ARCC preserves enough portfolio yield and fee income to offset rate normalization and spread competition, rather than letting the asset base reprice into materially weaker investment income.HoldingMateriality: High

    GAAP annual gross investment income rose from $1.820 billion in FY2021 to $3.052 billion in FY2025. The owner depends on spread income, not just portfolio size; if asset yields fall faster than funding costs, distributable earnings power weakens.

    Watch: Federal Reserve rate cuts and loan refinancings reduce asset yields faster than ARCC’s own borrowing costs decline.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross investment income rose from $1.820 billion in FY2021 to $3.052 billion in FY2025.

    Open source ↗
  • ARCC’s underwriting and portfolio monitoring prevent a middle-market credit-loss cycle from overwhelming coupon income and fair-value marks.HoldingMateriality: Medium

    GAAP annual net income was positive in every year shown from FY2021 through FY2025. BDC value can be destroyed quickly if non-accruals and write-downs consume income and capital, even when reported investment income remains high for a time.

    Watch: A recession or profit squeeze among sponsor-backed middle-market borrowers causes a wave of payment defaults and non-accruals.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual net income was positive in every year shown from FY2021 through FY2025.

    Open source ↗
  • ARCC retains a strong enough equity cushion and capital-market access to finance portfolio growth without stretching leverage into a downturn.StrengtheningMateriality: Medium

    GAAP stockholders’ equity at fiscal year-end increased from $8.868 billion in FY2021 to $14.318 billion in FY2025. If funding stays resilient, ARCC can be a liquidity provider when competitors pull back; if funding weakens, it may be forced to shrink, issue dilutively, or miss attractive loans.

    Watch: Credit-rating pressure or a private-credit funding shock materially raises ARCC’s unsecured debt costs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP stockholders’ equity at fiscal year-end increased from $8.868 billion in FY2021 to $14.318 billion in FY2025.

    Open source ↗
  • Incremental capital deployment remains accretive after funding costs, credit costs, and external-manager economics, so growth translates into per-share earnings power rather than dilution.HoldingMateriality: Medium

    GAAP annual diluted EPS was positive in every year shown from FY2021 through FY2025. For shareholders, a bigger portfolio is only valuable if each share owns equal or better earnings power; otherwise scale benefits the manager more than the owner.

    Watch: ARCC issues equity below NAV or raises capital at a cost that exceeds the returns available on new loans.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual diluted EPS was positive in every year shown from FY2021 through FY2025.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Ares Capital’s specialty-finance platform continues to replenish the portfolio because borrowers still choose private credit over bank or syndicated-market alternatives. If sourcing remains advantaged, ARCC can keep redeploying capital into income-producing assets; if deal flow migrates elsewhere, the portfolio and earnings base erode.

ARCC preserves enough portfolio yield and fee income to offset rate normalization and spread competition, rather than letting the asset base reprice into materially weaker investment income. The owner depends on spread income, not just portfolio size; if asset yields fall faster than funding costs, distributable earnings power weakens.

ARCC’s underwriting and portfolio monitoring prevent a middle-market credit-loss cycle from overwhelming coupon income and fair-value marks. BDC value can be destroyed quickly if non-accruals and write-downs consume income and capital, even when reported investment income remains high for a time.

ARCC retains a strong enough equity cushion and capital-market access to finance portfolio growth without stretching leverage into a downturn. If funding stays resilient, ARCC can be a liquidity provider when competitors pull back; if funding weakens, it may be forced to shrink, issue dilutively, or miss attractive loans.

Incremental capital deployment remains accretive after funding costs, credit costs, and external-manager economics, so growth translates into per-share earnings power rather than dilution. For shareholders, a bigger portfolio is only valuable if each share owns equal or better earnings power; otherwise scale benefits the manager more than the owner.

All standing thesis claims
Original report summary

Ares can keep sourcing private-credit assets at attractive spreads while avoiding the credit losses and funding stress that destroy BDC book value.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Ares Capital

Where the evidence on Ares Capital stands: Holding on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 2 strengthening and 3 holding.

Bull case: what the evidence supports

  • Ares Capital’s specialty-finance platform continues to replenish the portfolio because borrowers still choose private credit over bank or syndicated-market alternatives.

    sec.gov ↗

  • ARCC preserves enough portfolio yield and fee income to offset rate normalization and spread competition, rather than letting the asset base reprice into materially weaker investment income.

    sec.gov ↗

  • ARCC’s underwriting and portfolio monitoring prevent a middle-market credit-loss cycle from overwhelming coupon income and fair-value marks.

    sec.gov ↗

  • ARCC retains a strong enough equity cushion and capital-market access to finance portfolio growth without stretching leverage into a downturn.

    sec.gov ↗

  • Incremental capital deployment remains accretive after funding costs, credit costs, and external-manager economics, so growth translates into per-share earnings power rather than dilution.

    sec.gov ↗

Bear case: what would count against it

  • Banks and the broadly syndicated loan market reopen aggressively and undercut private-credit pricing for ARCC’s target borrowers.

    sec.gov ↗

  • Federal Reserve rate cuts and loan refinancings reduce asset yields faster than ARCC’s own borrowing costs decline.

    sec.gov ↗

  • A recession or profit squeeze among sponsor-backed middle-market borrowers causes a wave of payment defaults and non-accruals.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Ares Capital

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Ares Capital’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Ares Capital filed an SEC 8-K on 2026-09-15: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Ares Capital filed an SEC 8-K on 2026-07-29: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Entered a material definitive agreement.

    Ares Capital filed an SEC 8-K on 2026-07-22: Entered a material definitive agreement. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Banks and the broadly syndicated loan market reopen aggressively and undercut private-credit pricing for ARCC’s target borrowers.
  • Federal Reserve rate cuts and loan refinancings reduce asset yields faster than ARCC’s own borrowing costs decline.
  • A recession or profit squeeze among sponsor-backed middle-market borrowers causes a wave of payment defaults and non-accruals.
  • Credit-rating pressure or a private-credit funding shock materially raises ARCC’s unsecured debt costs.
  • ARCC issues equity below NAV or raises capital at a cost that exceeds the returns available on new loans.

ARCC news

Loading headlines…

Financial statements

ARCC income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

ARCC: quick answers

When does Ares Capital (ARCC) report earnings next?
Ares Capital's next results are projected for February 3, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 27, 2026. Earnings calendar
What is ARCC's short interest?
As of October 30, 2026, 36.4M ARCC shares were sold short, down 9.2% from the count before. At the stock's average daily volume that is 7.5 days to cover. FINRA publishes the count twice a month. ARCC short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.